What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?

Bioanalysis

Volumn 7, Issue 3, 2015, Pages 345-351

  Koster, Remco A ^a   Alffenaar, Jan Willem C ^a   Botma, Rixt ^a   Greijdanus, Ben ^a   Touw, Daan J ^a,b   Uges, Donald R A ^a   Kosterink, Jos G W ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRIFUGATION; DRIED BLOOD SPOT TESTING; ERYTHROCYTE; HEMATOCRIT; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUALITY CONTROL; STANDARD; VALIDATION PROCESS; BLOOD SAMPLING; CYTOLOGY; PROCEDURES; STANDARDS;

BLOOD SPECIMEN COLLECTION; DRIED BLOOD SPOT TESTING; ERYTHROCYTES; HEMATOCRIT; HUMANS; QUALITY CONTROL; REFERENCE STANDARDS;

EID: 84923321793     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.298     Document Type: Article

References (30)

1. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24(1), 49-65 (2010).
2. Vu DH, Alffenaar JW, Edelbroek PM, Brouwers JR, Uges DR. Dried blood spots: a new tool for tuberculosis treatment optimization. Curr. Pharm. Des. 17(27), 2931-2939 (2011).
3. Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther. Drug Monit. 31(3), 327-336 (2009).
4. Chapman K, Chivers S, Gliddon D et al. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discov. Today 19(5), 528-532 (2014).
5. Wilhelm AJ, den Burger JC, Swart EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin. Pharmacokinet. 53(11), 961-973 (2014).
6. Koster RA, Alffenaar JW, Greijdanus B, Uges DR. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta 115, 47-54 (2013).
7. Vu DH, Koster RA, Alffenaar JW, Brouwers JR, Uges DR. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 879(15-16), 1063-1070 (2011).
8. den Burger JC, Wilhelm AJ, Chahbouni A, Vos RM, Sinjewel A, Swart EL. Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem. 404(6-7), 1803-1811 (2012).
9. Moller I, Thomas A, Geyer H, Schanzer W, Thevis M. Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. Anal. Bioanal. Chem. 403(9), 2715-2724 (2012).
10. Mess JN, Taillon MP, Cote C, Garofolo F. Dried blood spot on-card derivatization: an alternative form of sample handling to overcome the instability of thiorphan in biological matrix. Biomed. Chromatogr. 26(12), 1617-1624 (2012).
11. Patel AJ, Wesley R, Leitman SF, Bryant BJ. Capillary versus venous haemoglobin determination in the assessment of healthy blood donors. Vox Sang. 104(4), 317-323 (2013).
12. Youhnovski N, Bergeron A, Furtado M, Garofolo F. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact. Rapid. Commun. Mass Spectrom. 25(19), 2951-2958 (2011).
13. Kvaskoff D, Ko P, Simila HA, Eyles DW. Distribution of 25-hydroxyvitamin D3 in dried blood spots and implications for its quantitation by tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 901, 47-52 (2012).
14. Vu DH, Koster RA, Bolhuis MS et al. Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS. Talanta 121, 9-17 (2014).
15. Rhoden L, Antunes MV, Hidalgo P, Silva CA, Linden R. Simple procedure for determination of valproic acid in dried blood spots by gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 96, 207-212 (2014).
16. Cox HD, Rampton J, Eichner D. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport. Anal. Bioanal. Chem. 405(6), 1949-1958 (2013).
17. O'Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 3(20), 2335-2347 (2011).
18. Zheng JH, Guida LA, Rower C et al. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS. J. Pharm. Biomed. Anal. 88, 144-151 (2014).
19. Shah NM, Hawwa AF, Millership JS, Collier PS, McElnay JC. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 923-924, 65-73 (2013).
20. Jimmerson LC, Zheng JH, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 944, 18-24 (2014).
21. Rao RN, Raju SS, Vali RM, Sankar GG. Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 902, 47-54 (2012).
22. Rao RN, Maurya PK, Ramesh M, Srinivas R, Agwane SB. Development of a validated high-Throughput LC-ESI-MS method for determination of sirolimus on dried blood spots. Biomed. Chromatogr. 24(12), 1356-1364 (2010).
23. Wilhelm AJ, den Burger JC, Vos RM, Chahbouni A, Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(14-15), 1595-1598 (2009).
24. Hinchliffe E, Adaway JE, Keevil BG. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. (2011).
25. van der Heijden J, de Beer Y, Hoogtanders K et al. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 50(4), 664-670 (2009).
26. Koop DR, Bleyle LA, Munar M, Cherala G, Al-Uzri A. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 926, 54-61 (2013).
27. Della Bona ML, Malvagia S, Villanelli F et al. A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots. J. Pharm. Biomed. Anal. 78-79, 34-38 (2013).
28. Patel P, Tanna S, Mulla H, Kairamkonda V, Pandya H, Lawson G. Dexamethasone quantification in dried blood spot samples using LC-MS: the potential for application to neonatal pharmacokinetic studies. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(31), 3277-3282 (2010).
29. DIN Deutsches Institut fur Normung. Bestimmung des Volumenanteils der Erythrocyten im Blut. DIN, Berlin (1995).
30. NCCLS. Procedure for Determining Packed Cell Volume by the Microhematocrit Method; Approved Standard. NCCLS document H7-A3 [ISBN 1-56238-56413-419] (2000).